Contact

Aposcience AG

Dresdner Stra├če 87/A 21
1200 Vienna
Austria
P: +43 / (0)664 / 212 05 57
E: info(at)aposcience.com

FN: 308089 y
ATU64127689
FG: Wien

Latest News
Aug
31

Approval of DSMB for Lead In-Phase and Go-Ahead for MARSYAS II Main Study

[more]

May
27

Approval for clinical phase II study in DFU by German health agency PEI

[more]